UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Beyond viral suppression of HIV - the new quality of life frontier

BMC medicine, 2016-06, Vol.14 (1), p.94-94, Article 94

2016

Volltextzugriff (PDF)

Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients

PloS one, 2018-01, Vol.13 (1), p.e0191118-e0191118

2018

Volltextzugriff (PDF)

HIV/AIDS knowledge and attitudes towards HIV and condom use among internally displaced Libyan males. Is there a need to implement sex education?

HIV research & clinical practice, 2024-01, Vol.25 (1), p.2305554-2305554

2024

Volltextzugriff (PDF)

Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART

PloS one, 2019-07, Vol.14 (7), p.e0219526-e0219526

2019

Volltextzugriff (PDF)

Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)

PloS one, 2017-06, Vol.12 (6), p.e0178685-e0178685

2017

Volltextzugriff (PDF)

HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans

Infection, 2016-04, Vol.44 (2), p.151-158

2016

Volltextzugriff (PDF)

Selection and Counterselection of the rtI233V Adefovir Resistance Mutation during Antiviral Therapy

Journal of Clinical Microbiology, 2010-02, Vol.48 (2), p.631-634

2010

Volltextzugriff (PDF)

Hepatitis C virus treatment in the real world: optimising treatment and access to therapies

Gut, 2015-11, Vol.64 (11), p.1824-1833

2015

Volltextzugriff (PDF)

Detection of a Sexually Transmitted Hepatitis C Virus Protease Inhibitor-Resistance Variant in a Human Immunodeficiency Virus–Infected Homosexual Man

Gastroenterology (New York, N.Y. 1943), 2014-09, Vol.147 (3), p.599-601.e1

2014

Volltextzugriff (PDF)

Circulating MicroRNAs as a marker for liver injury in human immunodeficiency virus patients

Hepatology (Baltimore, Md.), 2015-01, Vol.61 (1), p.46-55

2015

Volltextzugriff (PDF)

Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV

BMC infectious diseases, 2023-01, Vol.23 (1), p.52-52, Article 52

2023

Volltextzugriff (PDF)

HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients

Journal of virological methods, 2017-07, Vol.245, p.14-18

2017

Volltextzugriff (PDF)

Noninvasive Markers for Monitoring Fibrosis Regression After Hepatitis C Virus Cure: What Do They Promise?

Clinical infectious diseases, 2021-08, Vol.73 (3), p.478-479

Rockstroh, Jürgen Kurt

2021

Volltextzugriff (PDF)

Survival and HLA-B57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)

PloS one, 2015-08, Vol.10 (8), p.e0134158-e0134158

2015

Volltextzugriff (PDF)

Is Hepatitis C Virus Elimination in Well-Defined Patient Groups Possible?

Clinical infectious diseases, 2018-05, Vol.66 (9), p.1366-1367

Rockstroh, Jürgen Kurt

2018

Volltextzugriff (PDF)

Massive Paraesophageal Varices in the Absence of Liver Cirrhosis

Deutsches Ärzteblatt international, 2017-10, Vol.114 (41), p.701-701

2017

Volltextzugriff (PDF)

HCV cure for everyone or which challenges remain?

Journal of virus eradication, 2015-04, Vol.1 (2), p.55-58

Rockstroh, Jürgen Kurt

2015

Volltextzugriff (PDF)

Diagnosis and Treatment of Acute Hepatitis C Virus Infection

Infectious disease clinics of North America, 2012-12, Vol.26 (4), p.995-1010

2012

Volltextzugriff (PDF)

HepCare Europe: a new user-friendly hepatitis C care service model. What have we learned? What are the remaining challenges?

Journal of antimicrobial chemotherapy, 2019-11, Vol.74 (Suppl 5), p.v2-v4

2019

Volltextzugriff (PDF)

Hepatitis C Micro-elimination in Human Immunodeficiency Virus–Coinfected Men Who Have Sex With Men: A Low Hanging Fruit?

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e2203-e2204

Rockstroh, Jürgen Kurt

2021

Volltextzugriff (PDF)

Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy

Antiviral therapy, 2014-01, Vol.19 (4), p.407-414

2014

Volltextzugriff (PDF)

Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have Sex With Men

The Journal of infectious diseases, 2020-12, Vol.222 (Supplement_9), p.S782-S788

2020

Volltextzugriff (PDF)

Management of drug‐to‐drug interactions between cyclosporine A and the protease‐inhibitor lopinavir/ritonavir in liver‐transplanted HIV‐infected patients

Liver transplantation, 2004-07, Vol.10 (7), p.939-944

2004

Volltextzugriff (PDF)

HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans

Infection, 2016-04, Vol.44 (2), p.151-158

2016

Volltextzugriff (PDF)

Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time

Reviews in medical virology, 2016-11, Vol.26 (6), p.408-434

2016

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(83)
Deutsch
(11)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Humans
(58)
Life Sciences & Biomedicine
(58)
Hiv
(33)
Infectious Diseases
(33)
Hiv Infections - Drug Therapy
(30)
Male
(29)
Human Immunodeficiency Virus
(25)
Adult
(22)
Female
(19)
Hiv Infections - Complications
(19)
Immunology
(17)
Antiviral Agents - Therapeutic Use
(15)
Middle Aged
(15)
Hiv Infections - Virology
(14)
Virology
(14)
Biological And Medical Sciences
(13)
Hepatitis C
(13)
Treatment Outcome
(13)
Antiretroviral Therapy, Highly Active
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Beyond viral suppression of HIV - the new quality of life frontier

Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients

HIV/AIDS knowledge and attitudes towards HIV and condom use among internally displaced Libyan males. Is there a need to implement sex education?

Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART

Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)

HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans

Selection and Counterselection of the rtI233V Adefovir Resistance Mutation during Antiviral Therapy

Hepatitis C virus treatment in the real world: optimising treatment and access to therapies

Detection of a Sexually Transmitted Hepatitis C Virus Protease Inhibitor-Resistance Variant in a Human Immunodeficiency Virus–Infected Homosexual Man

Circulating MicroRNAs as a marker for liver injury in human immunodeficiency virus patients

Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV

HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients

Noninvasive Markers for Monitoring Fibrosis Regression After Hepatitis C Virus Cure: What Do They Promise?

Survival and HLA-B57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)

Is Hepatitis C Virus Elimination in Well-Defined Patient Groups Possible?

Massive Paraesophageal Varices in the Absence of Liver Cirrhosis

HCV cure for everyone or which challenges remain?

Diagnosis and Treatment of Acute Hepatitis C Virus Infection

HepCare Europe: a new user-friendly hepatitis C care service model. What have we learned? What are the remaining challenges?

Hepatitis C Micro-elimination in Human Immunodeficiency Virus–Coinfected Men Who Have Sex With Men: A Low Hanging Fruit?

Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy

Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have Sex With Men

Management of drug‐to‐drug interactions between cyclosporine A and the protease‐inhibitor lopinavir/ritonavir in liver‐transplanted HIV‐infected patients

HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans

Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time

Suchergebnisse filtern